Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis
- PMID: 2829950
- DOI: 10.1089/aid.1987.3.265
Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis
Abstract
The Human Immunodeficiency Virus (HIV), the causative agent of AIDS, is thought to bind to T4+ (CD4+) target cells through the heavily glycosylated gp120 envelope glycoprotein. Plant lectins bind glycoproteins through noncovalent interaction with specific hexose residues; therefore, lectins were evaluated for their ability to inactivate HIV in vitro. The mannose-specific lectins concanavalin-A and succinyl concanavalin-A completely inactivated HIV while lentil lectin, wheat germ agglutinin, and phytohemagglutinin-P substantially inactivated HIV. BS-II, Vicia villosa (hairy vetch), and Ptilota plumosa (red marine algae) failed to alter the infectibility of HIV. Neither simple stearic hindrance, viral aggregation, nor lectin-cell interactions served to explain this phenomenon. Glycoprotein glycosylation was evaluated by differential lectin binding as well as molecular weight changes in gp120 when virus was produced in the presence of swainsonine, a glycosylation inhibitor. Lentil lectin bound gp120 better than concanavalin-A, suggesting the majority of glycosylation sites are fucosylated. The apparent molecular weight of gp120 was reduced by swainsonine, although HIV infectivity and concanavalin-A inactivation were retained. Thus, at least some N-glycosylation sites are complex-type glycoproteins but regions external to the (GlcNAc)2(Man)3 "core" pentasaccharide region are not required for HIV infectivity. It appears that the site or sites involved are nonfucosylated, high mannose and/or biantennary, nonsialylated, N-glycosylated regions of gp120 or gp41. Alternatively, they may be in close approximation to such carbohydrate regions.
Similar articles
-
Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.Proc Natl Acad Sci U S A. 1989 May;86(9):3384-8. doi: 10.1073/pnas.86.9.3384. Proc Natl Acad Sci U S A. 1989. PMID: 2541446 Free PMC article.
-
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.J Exp Med. 1989 Mar 1;169(3):807-22. doi: 10.1084/jem.169.3.807. J Exp Med. 1989. PMID: 2538547 Free PMC article.
-
Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1.J Gen Virol. 2000 Apr;81(Pt 4):949-55. doi: 10.1099/0022-1317-81-4-949. J Gen Virol. 2000. PMID: 10725420
-
CD4 activation of HIV fusion.Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review.
-
[Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1].Nihon Rinsho. 1992 Jun;50(6):1419-29. Nihon Rinsho. 1992. PMID: 1518160 Review. Japanese.
Cited by
-
Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro.Antimicrob Agents Chemother. 1991 Mar;35(3):410-6. doi: 10.1128/AAC.35.3.410. Antimicrob Agents Chemother. 1991. PMID: 1645507 Free PMC article.
-
Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization.J Virol. 2010 Jun;84(11):5637-55. doi: 10.1128/JVI.00105-10. Epub 2010 Mar 24. J Virol. 2010. PMID: 20335257 Free PMC article.
-
Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120.Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8356-60. doi: 10.1073/pnas.89.17.8356. Proc Natl Acad Sci U S A. 1992. PMID: 1518869 Free PMC article.
-
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.J Virol. 2000 Aug;74(15):6769-76. doi: 10.1128/jvi.74.15.6769-6776.2000. J Virol. 2000. PMID: 10888615 Free PMC article.
-
HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.Expert Opin Ther Targets. 2015 Jun;19(6):765-83. doi: 10.1517/14728222.2015.1010513. Epub 2015 Feb 27. Expert Opin Ther Targets. 2015. PMID: 25724219 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials